Quantitative proteome and lysine succinylome analyses provide insights into metabolic regulation in breast cancer
- 125 Downloads
Breast cancer, the most common invasive cancer and cause of cancer-related death in women worldwide, is a multifactorial, complex disease, and many molecular players and mechanisms underlying the complexity of its clinical behavior remain unknown.
To explore the molecular features of breast cancer, quantitative proteome and succinylome analyses in breast cancer were extensively studied using quantitative proteomics techniques, anti-succinyl lysine antibody-based affinity enrichment, and high-resolution LC–MS/MS analysis.
Our study is the first to detect the regulation of lysine succinylation in breast cancer progression. We identified a novel mechanism by which the pentose phosphate pathway and the endoplasmic reticulum protein processing pathway might be regulated via lysine succinylation in their core enzymes.
These results expand our understanding of tumorigenesis mechanisms and provide a basis for further characterization of the pathophysiological roles in breast cancer progression, laying a foundation for innovative and novel breast cancer drugs and therapies.
KeywordsBreast cancer Proteomics Lysine succinylation Quantitative analysis Bioinformatics analysis
We thank the individuals and families who participated in this project. We would also like to thank the participants who helped to collect samples from Hospital No. 1, Anhui Medical University, China. Additionally, we thank the State Key Laboratory Incubation Base of Dermatology, Ministry of National Science and Technology (Hefei, China).
Compliance with ethical standards
Conflict of interest
The authors have declared that no competing interest exists.
- 6.Belizario JE, Sangiuliano BA, Perez-Sosa M, Santos BV, Machado-Santelli G. Advances in the integration of optical and mass spectrometry molecular imaging technologies: from omics data to molecular signature discovery. Discov Med. 2015;20(112):393–401.Google Scholar
- 29.Heinrich PC, Morris HP, Weber G. Behavior of transaldolase (EC 220.127.116.11) and transketolase (EC 18.104.22.168) Activities in normal, neoplastic, differentiating, and regenerating liver. Cancer Res. 1976;36(9 pt.1):3189–97.Google Scholar